Elmira Roshani Asl
Overview
Explore the profile of Elmira Roshani Asl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tahmasebi F, Asl E, Vahidinia Z, Faghihi F, Barati S
Mol Biol Rep
. 2024 May;
51(1):674.
PMID: 38787497
Background: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) with inflammation and immune dysfunction. Objectives: We compared the remyelination and immunomodulation properties of mesenchymal...
2.
Tahmasebi F, Asl E, Vahidinia Z, Barati S
Cell Mol Neurobiol
. 2024 May;
44(1):44.
PMID: 38713302
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by inflammation and demyelination of CNS neurons. Up to now, there are many therapeutic strategies for...
3.
Rasmi Y, di Bari I, Faisal S, Haque M, Aramwit P, da Silva A, et al.
Mol Biol Rep
. 2024 Feb;
51(1):316.
PMID: 38376656
Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide, being responsible for about 3.5 million deaths so far. Despite ongoing investigations, there is still more to understand...
4.
Shahcheraghi S, Asl E, Lotfi M, Ayatollahi J, Khaleghinejad S, Aljabali A, et al.
CNS Neurol Disord Drug Targets
. 2024 Jan;
23(10):1203-1216.
PMID: 38279763
Glioblastoma multiforme (GBM) is a highly invasive brain malignancy originating from astrocytes, accounting for approximately 30% of central nervous system malignancies. Despite advancements in therapeutic strategies including surgery, chemotherapy, and...
5.
Rasoolnezhad M, Safaralizadeh R, Feizi M, Banan-Khojasteh S, Asl E, Lotfinejad P, et al.
Mol Biol Rep
. 2023 Aug;
50(10):8407-8420.
PMID: 37620737
Background: Chemotherapy is a predominant strategy for breast cancer (BC) treatment and paclitaxel (PTX) has been known as a conventional chemotherapeutic drug. However, insensitivity of BC cells to PTX limits...
6.
Asl E, Sarabandi S, Shademan B, Dalvandi K, Sheikhansari G, Nourazarian A
Biochem Biophys Rep
. 2023 Jul;
35:101519.
PMID: 37521375
Ovarian cancer, a perilous form of cancer affecting the female reproductive system, exhibits intricate communication networks that contribute to its progression. This study aims to identify crucial molecular abnormalities linked...
7.
Asl E, Rostamzadeh D, Duijf P, Mafi S, Mansoori B, Barati S, et al.
Life Sci
. 2023 Jan;
315:121361.
PMID: 36608871
TP53 is the most frequently mutated gene in human cancer. It encodes the tumor suppressor protein p53, which suppresses tumorigenesis by acting as a critical transcription factor that can induce...
8.
Nemati M, Fathi-Azarbayjani A, Al-Salami H, Asl E, Rasmi Y
Cell Biochem Funct
. 2022 Jul;
40(6):623-635.
PMID: 35830577
Diabetes mellitus affects almost half a billion patients worldwide and results from either destruction of β-cells responsible for insulin secretion or increased tissue resistance to insulin stimulation and the reduction...
9.
Dastmalchi N, Azarbarzin S, Safaralizadeh R, Khojasteh S, Shadbad M, Amini M, et al.
Med Oncol
. 2021 Nov;
39(1):9.
PMID: 34761351
The deregulation of microRNAs (miRs) has been identified in tumor development. Indeed, the restoration of tumor-suppressive miRs has been associated with inhibited tumor development in various cancers. Herein, we aimed...
10.
Asl E, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, et al.
Life Sci
. 2021 Apr;
278:119499.
PMID: 33865878
Mitogen-activated protein kinase (MAPK) signal transduction, as a highly conserved signaling pathway, is reported to be involved in various biological events, including metabolic reprogramming, cell proliferation, survival, and differentiation. Mutations...